Friederike Zahm
Hoffmann-La Roche
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Friederike Zahm.
Chemotherapy | 1988
Asbjørn Digranes; Eva Benonisen; Aud Salveson; Friederike Zahm
The in vitro activity of fleroxacin (Ro 23-6240) against 441 bacterial isolates was compared with those of ciprofloxacin, ofloxacin, amoxycillin, cefadroxil, cefuroxime and tobramycin. An agar dilution method was used for the determination of minimal inhibitory concentrations (MICs). Ciprofloxacin showed the highest activity against the Enterobacteriaceae, 95% of the isolates were inhibited by 0.06 mg/l, but fleroxacin and ofloxacin were also highly active (MIC 90% = 0.5 and 0.25 mg/l, respectively). Ciprofloxacin was the most active agent against Pseudomonas aeruginosa (MIC 90% = 0.12 mg/l), whereas the activities of fleroxacin and ofloxacin were more variable. Tobramycin was highly active against P. aeruginosa, 75% of the isolates were inhibited by 0.5 mg/l or less. The quinolones and tobramycin exhibited high activity against Acinetobacter calcoaceticus, the great majority of the isolates being susceptible to 0.5 mg/l or less of any agent. All the quinolones showed high activity against Staphylococcus aureus, but fleroxacin was less active against Staphylococcus epidermidis and Staphylococcus saprophyticus than were the other derivatives. The pneumococcal and streptococcal isolates were markedly less susceptible to fleroxacin than to the other quinolones tested (MIC range 4-32 mg/l). All isolates of Haemophilus influenzae and Neisseria gonorrhoeae were inhibited by the lowest concentration of the quinolones employed in the study (0.03 mg/l). Cefuroxime was also highly active against N. gonorrhoeae, whether the strains were beta-lactamase-producing or not, but was somewhat less active against H. influenzae. The quinolones displayed moderate and similar activity against Bacteroides fragilis isolates (MIC range 1-16 mg/l). The MICs of fleroxacin against gram-negative rods were generally 4-16 times higher at pH 8.8 than those obtained at pH 5.8 and 7.3. The activity against gram-positive cocci was not markedly influenced by changes in pH.
Hepatology | 1999
Vicente Carreño; Patrick Marcellin; Stephanos J. Hadziyannis; Javier Salmerón; M. Diago; Geoge E. Kitis; Irene Vafiadis; Solko W. Schalm; Friederike Zahm; Félix Manzarbeitia; F. Javier Jiménez; Juan Antonio Quiroga
Archive | 1999
Friederike Zahm
Antiviral Research | 1999
Julio Martı́n; Sonia Navas; Mario Fernández; Miguel Rico; Margarita Pardo; Juan Antonio Quiroga; Friederike Zahm; Vicente Carreño
Hepatology | 1999
Carreño; Patrick Marcellin; Stephanos J. Hadziyannis; Javier Salmerón; M. Diago; Geoge E. Kitis; Irene Vafiadis; Solko W. Schalm; Friederike Zahm; Félix Manzarbeitia; Jiménez Fj; Juan Antonio Quiroga
Gastroenterology | 1994
Francesco Negro; Maurizio Baldi; Alessandra Mondardini; Gioacchino Leandro; Monique Chaneac; Paola Manzini; Maria Lorena Abate; Friederike Zahm; Giuseppe Dastoli; Marco Ballaré; Jean-Charles Ryff; Giorgio Verme
Hepatology | 1999
Calogero Cammà; Marco Giunta; Liliana Chemello; Alfredo Alberti; Hidenori Toyoda; Christian Trepo; Patrick Marcellin; Friederike Zahm; Solko W. Schalm; A. Craxì
Archive | 2001
Mary C. Graves; Stephen C. Pappas; Friederike Zahm
Hepatology | 1999
Calogero Cammà; Marco Giunta; Liliana Chemello; Alfredo Alberti; Hidenori Toyoda; Christian Trepo; Patrick Marcellin; Friederike Zahm; Solko W. Schalm; A. Craxì
Antiviral Research | 2007
Klaus Klumpp; David Bernard Smith; Michael Brandl; Tom Alfredson; Keshab Sarma; Mark Smith; Isabel Najera; Wen-Rong Jiang; Sophie Le Pogam; Vincent Leveque; Han Ma; Yaping Tu; Rebecca Chan; Chiao-Wen Chen; Xiaoyang Wu; Raj Birudaraj; Steven Swallow; Joseph A. Martin; Nick Cammack; Heather Berns; Scott Fettner; Marie Mannino; Edward O’Mara; Carla Washington; Stuart K. Roberts; Graham Cooksley; Greg Dore; David Shaw; David R. Blue; Friederike Zahm